Oncology Institute Inc.

NASDAQ: TOI · Real-Time Price · USD
3.56
-0.11 (-3.00%)
At close: Aug 15, 2025, 12:28 PM

Oncology Institute Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
424.38M 403.15M 393.41M 378.93M 361.07M 342.71M 324.24M 309.88M 292.82M 273.51M 252.48M 233.36M 220.66M 209.58M 203M 338.21M 333.19M 330.62M
Cost of Revenue
362.43M 343.88M 339.42M 325.19M 305.71M 285.27M 264.67M 249.05M 234.97M 219.64M 200.39M 188.57M 177.44M 166.62M 162.16M 184.91M 181.73M 180.57M
Gross Profit
61.95M 59.28M 54M 53.74M 55.35M 57.44M 59.57M 60.82M 57.84M 53.87M 52.09M 44.8M 43.22M 42.97M 40.85M 153.31M 151.46M 150.06M
Operating Income
-46.9M -52.06M -60.12M -63.48M -63.55M -62.12M -60.15M -60M -66.17M -69.54M -72.01M -97.7M -79.76M -62.58M -45.86M -12.74M -10.78M -9.53M
Interest Income
n/a n/a n/a n/a 940K 1.97M 3.18M 3.18M 2.24M 1.21M n/a n/a 5.8K 5.8K 5.8K 186.55K 254.15K 254.15K
Pretax Income
-66.02M -64.36M -64.66M -70.55M -71.72M -73.04M -83.1M -75.41M -60.82M -49.51M -91K -1.34M -823K 8.65M -11.6M -7.99M -8.21M -11.15M
Net Income
-65.89M -64.36M -64.66M -70.23M -71.54M -72.96M -83.07M -75.32M -60.58M -49.13M 152K 1M 697K 9.36M -10.93M -9.28M -8.72M -10.9M
Selling & General & Admin
103.79M 104.75M 107.83M 111.06M 112.62M 113.47M 113.85M 115.33M 119.09M 118.71M 119.69M 138.36M 119.13M 101.99M 83.37M 76.69M 64.11M 61.44M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
5.06M 6.58M 6.29M 6.16M 6.28M 6.09M 5.87M 5.49M 4.92M 4.69M 4.41M 3.14M 2.06M 957.35K 1.05M 4.15M 4.15M 5.17M
Operating Expenses
108.85M 111.33M 114.11M 117.22M 118.9M 119.57M 119.72M 120.82M 124.02M 123.41M 124.1M 142.5M 122.98M 105.54M 86.71M 82.14M 68.75M 66.1M
Interest Expense
10.83M 11.08M 7.5M 8.27M 8.74M 9.29M 9.96M 10.47M 9.27M 6.66M 4.08M 1.69M 273K 293K 320K 260K 182K 211.75K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 46.72M 57.92M 66.6M 77.65M 72.34M 61.14M 60.86M
Cost & Expenses
471.28M 455.21M 453.53M 442.41M 424.62M 404.84M 384.39M 369.87M 358.99M 343.05M 324.49M 331.07M 300.42M 272.16M 248.86M 350.96M 296.72M 292.9M
Income Tax Expense
-131K n/a n/a -314K -179K -80K -36K -89K -248K -379K -243K -2.34M -1.52M -707.94K -669.94K 1.29M 505.24K -245.61K
Shares Outstanding (Basic)
932.04M 77.1M 75.66M 75.52M 74.75M 74.23M 73.47M 73.47M 74.12M 73.45M 72.75M 79.58M 73M 73.25M 69.95M 74.59M 66.02M 66.02M
Shares Outstanding (Diluted)
932.04M 77.1M 75.66M 75.52M 74.75M 74.23M 73.47M 73.47M 74.12M 73.45M 85.59M 79.58M 73M 76.25M 69.95M 74.59M 66.02M 66.02M
EPS (Basic)
-0.68 -0.7 -0.71 -0.78 -0.79 -0.85 -1.04 -0.96 -0.8 -0.65 -0.02 -0.04 -0.04 0.08 -0.16 -0.31 -0.35 -0.38
EPS (Diluted)
-0.68 -0.7 -0.71 -0.78 -0.79 -0.85 -1.04 -0.94 -0.78 -0.63 -0.01 -0.05 -0.05 0.07 -0.16 -0.31 -0.35 -0.38
EBITDA
-48.32M -46.7M -50.88M -59.3M -59.88M -61.59M -71.21M -58.22M -45.39M -36.16M -26.09M -32M -33.51M -29.51M -13.78M -10.18M -8.8M -7.54M
EBIT
-55.19M -53.28M -57.17M -65.46M -66.16M -67.96M -78.57M -67.18M -53.8M -44.06M 3.99M 351K -551K 8.94M -11.28M -12.7M -10.8M -13.7M
Depreciation & Amortization
6.87M 6.58M 6.29M 6.16M 6.28M 6.09M 5.87M 5.49M 4.92M 4.69M 4.41M 4.14M 3.85M 3.55M 3.34M 3.21M 3.15M 3.16M